ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ACOR Acorda Therapeutics Inc

13.50
1.10 (8.87%)
Mar 18 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.10 8.87% 13.50 20:00:00
Open Price Low Price High Price Close Price Prev Close
12.40 12.40 14.10 13.50 12.40
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
1/11/202408:33EDGAR2Form 8-K - Current report
1/11/202408:01BWAcorda Therapeutics to Regain Global Commercialization..
12/01/202316:30EDGAR2Form 8-K - Current report
11/13/202316:16EDGAR2Form 8-K - Current report
11/13/202316:01BWAcorda Therapeutics Reports Third Quarter 2023 Financial..
11/06/202316:01BWAcorda Third Quarter 2023 Update: Webcast/Conference Call..
11/06/202308:00BWAcorda Therapeutics Announces Biopas Laboratories Submission..
8/08/202316:12EDGAR2Form 8-K - Current report
8/08/202316:01BWAcorda Therapeutics Reports Second Quarter 2023 Financial..
8/02/202308:00BWAcorda Therapeutics Announces Launch of New INBRIJA®..
8/01/202308:00BWAcorda Second Quarter 2023 Update: Webcast/Conference Call..
6/28/202317:08BWTom Burns Elected to the Acorda Therapeutics Board of..
6/26/202308:23BWAcorda Therapeutics Regains Compliance with Nasdaq Minimum..
6/26/202308:00BWAcorda Therapeutics Regains Compliance with Nadaq Minimum..
6/02/202316:01BWAcorda Therapeutics Announces Completion of 1-for-20 Reverse..
5/31/202316:01BWAcorda Therapeutics to Conduct 1-for-20 Reverse Stock Split
5/30/202308:00BWAcorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual..
5/11/202316:01BWAcorda Therapeutics Reports First Quarter 2023 Financial..
5/10/202307:00BWAcorda Therapeutics to Make June 2023 $6.2 Million Interest..
5/08/202307:00BWAcorda Therapeutics and Chance Pharmaceuticals Announce..
5/04/202309:41BWAcorda First Quarter 2023 Update: Webcast/Conference Call..
4/24/202308:00BWAcorda Therapeutics to Present INBRIJA® Data at the American..
4/03/202308:00BWAcorda Launches INBRIJA® TV Commercial for Parkinson’s..
3/27/202308:00BWAcorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual..

Your Recent History

Delayed Upgrade Clock